Hims & Hers Health Gross Profit 2020-2026 | HIMS
Hims & Hers Health annual/quarterly gross profit history and growth rate from 2020 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Hims & Hers Health gross profit for the quarter ending June 30, 2026 was $0.481B, a 15.52% increase year-over-year.
- Hims & Hers Health gross profit for the twelve months ending June 30, 2026 was $1.764B, a 14.98% increase year-over-year.
- Hims & Hers Health annual gross profit for 2025 was $1.733B, a 47.76% increase from 2024.
- Hims & Hers Health annual gross profit for 2024 was $1.173B, a 64.09% increase from 2023.
- Hims & Hers Health annual gross profit for 2023 was $0.715B, a 74.92% increase from 2022.
|
Hims & Hers Health Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2025 | $1,733 |
| 2024 | $1,173 |
| 2023 | $715 |
| 2022 | $409 |
| 2021 | $204 |
| 2020 | $109 |
| 2019 | $45 |
|
Hims & Hers Health Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2026-06-30 | $481 |
| 2026-03-31 | $397 |
| 2025-12-31 | $444 |
| 2025-09-30 | $442 |
| 2025-06-30 | $416 |
| 2025-03-31 | $431 |
| 2024-12-31 | $370 |
| 2024-09-30 | $318 |
| 2024-06-30 | $257 |
| 2024-03-31 | $229 |
| 2023-12-31 | $204 |
| 2023-09-30 | $187 |
| 2023-06-30 | $170 |
| 2023-03-31 | $153 |
| 2022-12-31 | $132 |
| 2022-09-30 | $114 |
| 2022-06-30 | $87 |
| 2022-03-31 | $75 |
| 2021-12-31 | $62 |
| 2021-09-30 | $55 |
| 2021-06-30 | $47 |
| 2021-03-31 | $40 |
| 2020-12-31 | $32 |
| 2020-09-30 | $31 |
| 2020-06-30 | $26 |
| 2020-03-31 | $21 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $6.498B | $2.348B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.168B | 43.07 |
| Tempus AI (TEM) | United States | $12.423B | 0.00 |
| 10x Genomics (TXG) | United States | $9.692B | 0.00 |
| Hinge Health (HNGE) | United States | $7.455B | 71.62 |
| Doximity (DOCS) | United States | $4.601B | 28.36 |
| Heartflow (HTFL) | United States | $4.202B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.688B | 243.22 |
| Privia Health (PRVA) | United States | $2.601B | 96.95 |
| Clover Health Investments (CLOV) | United States | $2.475B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.157B | 32.86 |
| Butterfly Network (BFLY) | United States | $2.077B | 0.00 |
| Schrodinger (SDGR) | United States | $1.716B | 0.00 |
| Omnicell (OMCL) | United States | $1.484B | 21.19 |
| Azenta (AZTA) | United States | $1.447B | 78.64 |
| Enovis (ENOV) | United States | $1.035B | 5.36 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.668B | 0.00 |
| Phreesia (PHR) | United States | $0.642B | 34.50 |
| Claritev (CTEV) | United States | $0.602B | 0.00 |
| Veradigm (MDRX) | United States | $0.594B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.586B | 0.00 |
| Evolent Health (EVH) | United States | $0.423B | 0.00 |
| Carlsmed (CARL) | United States | $0.416B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.371B | 0.00 |
| CapsoVision (CV) | United States | $0.319B | 0.00 |
| Standard BioTools (LAB) | United States | $0.271B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.145B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 6.41 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.064B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.058B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.051B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.025B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.005B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |